Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women

European Heart Journal

Volumn 27, Issue 18, 2006, Pages 2170-2176

  Lee, Duk Hee ^a   Silventoinen, Karri ^b   Hu, Gang ^b,c   Jacobs Jr , David R ^d,e   Jousilahti, Pekka ^b,f   Sundvall, Jouko ^c   Tuomilehto, Jaakko ^b,c,g  

^a Kyungpook National University School of Medicine   (South Korea)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF OSLO   (Norway)

^f TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^g SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

Coronary heart disease; Diabetes; Gamma glutamyltransferase; Myocardial infarction; Oxidative stress

Indexed keywords

ALCOHOL; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENZYME ASSAY; FATALITY; FEMALE; FINLAND; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ALCOHOL DRINKING; CORONARY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; FINLAND; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 33748760084     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl086     Document Type: Article

References (24)

1. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355.
2. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005;112:2078-2080.
3. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, Pompella A. Atherosclerotic plaques contain gamma-glutamyl transpeptidase activity. Circulation 2004;109:1140.
4. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischaemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
5. Karlson BW, Wiklund O, Hallgren P, Sjolin M, Lindqvist J, Herlitz J. 10-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 2000;247:449-456.
6. Emdin M, Passino C, Michelassi C, Titta F, L'abbate A, Donato L, Pompella A, Paolicchi A. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001;22:1802-1807.
7. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H; Vorarlberg Health Monitoring Promotion Program Study Group. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163 944 Austrian adults. Circulation 2005;112:2130-2137.
8. Meisinger C, Doring A, Schneider A, Lowel H; for the KORA Study Group. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 2006; Published online ahead of print.
9. Lee DH, Jacobs DR Jr, Gross M, Steffes M. Serum gamma glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2005;51:1185-1191.
10. Tunstall-Padoe H; for the WHO MONICA Project. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-114.
11. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 2000;29:49-56.
12. Pajak A, Kuulasmaa K, Tuomilehto J, Ruokokoski E. The WHO MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 25-64 years. World Health Stat Q 1988;41:115-140.
13. Mahonen M, Salomaa V, Brommels M, Molarius A, Miettinen H, Pyorala K, Tuomilehto J, Arstila M, Kaarsalo E, Ketonen M, Kuulasmaa K, Lehto S, Mustaniemi H, Niemela M, Palomaki P, Torppa J, Vuorenmaa T. The validity of hospital discharge register data on coronary heart disease in Finland. Eur J Epidemiol 1997;13:403-415.
14. Palomaki P, Miettinen H, Mustaniemi H, Lehto S, Pyorala K, Mahonen M, Tuomilehto J. Diagnosis of acute myocardial infarction by MONICA and FINMONICA diagnostic criteria in comparison with hospital discharge diagnosis. J Clin Epidemiol 1994;47:659-666.
15. Lee DH, Silventoinen K, Jacobs DR Jr, Jousilahti P, Tuomileto J. Gamma-glutamyltransferase, obesity, and the risk of type-2 diabetes: observational cohort study among 20 158 middle-aged men and women. J Clin Endocrinol Metab 2004;89:5410-5414.
16. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE Project Group. Estimation of 10-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
17. Ulmer H, Kollerits B, Kelleher C, Diem G, Concin H. Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women. Eur J Cardiovasc Prev Rehabil 2005;12:433-441.
18. Lee DH, Ha MH, Kim JR, Gross M, Jacobs DR Jr. Gamma-glutamyltransferase, alcohol, and blood pressure. A 4-year follow-up study. Ann Epidemiol 2002;12:90-96.
19. Poikolainen K, Karkkainen P, Pikkarainen J. Correlations between biological markers and alcohol intake as measured by diary and questionnaire in men. J Stud Alcohol 1985;46:383-387.
20. Whitfield JB, Zhu G, Nestler JE, Heath AC, Martin NG. Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin Chem 2002;48:1426-1431.
21. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
22. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-369.
23. Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. Gamma glutamyltransferase is a predictor of incident diabetes and hypertension: the CARDIA Study. Clin Chem 2003;49:1358-1366.
24. Lee DH, Jacobs DR Jr. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 2005;178:327-330.